Literature DB >> 17278083

Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Lionel A Mandell1, Richard G Wunderink, Antonio Anzueto, John G Bartlett, G Douglas Campbell, Nathan C Dean, Scott F Dowell, Thomas M File, Daniel M Musher, Michael S Niederman, Antonio Torres, Cynthia G Whitney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17278083      PMCID： PMC7107997          DOI： 10.1086/511159

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  331 in total

1.  Outbreak of Legionnaires' disease associated with a display whirlpool spa.

Authors:  D H Benkel; E M McClure; D Woolard; J V Rullan; G B Miller; S R Jenkins; J H Hershey; R F Benson; J M Pruckler; E W Brown; M S Kolczak; R L Hackler; B S Rouse; R F Breiman
Journal:  Int J Epidemiol       Date:  2000-12       Impact factor: 7.196

2.  High-resolution computed tomography for the diagnosis of community-acquired pneumonia.

Authors:  H Syrjälä; M Broas; I Suramo; A Ojala; S Lähde
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

3.  Sputum gram's stain in community-acquired pneumococcal pneumonia. A meta-analysis.

Authors:  W W Reed; G S Byrd; R H Gates; R S Howard; M J Weaver
Journal:  West J Med       Date:  1996-10

4.  Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia.

Authors:  S Schönwald; V Skerk; I Petricevic; V Car; L Majerus-Misic; M Gunjaca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

5.  Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors.

Authors:  E J Gorak; S M Yamada; J D Brown
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

6.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

7.  Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

Authors:  Brendan Flannery; Stephanie Schrag; Nancy M Bennett; Ruth Lynfield; Lee H Harrison; Arthur Reingold; Paul R Cieslak; James Hadler; Monica M Farley; Richard R Facklam; Elizabeth R Zell; Cynthia G Whitney
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults.

Authors:  Aida E Casiano-Colón; Barbara B Hulbert; Theodor K Mayer; Edward E Walsh; Ann R Falsey
Journal:  J Clin Virol       Date:  2003-10       Impact factor: 3.168

9.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.

Authors:  O Leroy; C Santré; C Beuscart; H Georges; B Guery; J M Jacquier; G Beaucaire
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

10.  Decreasing beta-lactam resistance in Pneumococci from the Memphis region: analysis of 2,152 isolates From 1996 to 2001.

Authors:  Grant W Waterer; Steven C Buckingham; Lori A Kessler; Michael W Quasney; Richard G Wunderink
Journal:  Chest       Date:  2003-08       Impact factor: 9.410
View more
  1633 in total

1.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

2.  Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us?

Authors:  Michael S Niederman
Journal:  Chest       Date:  2010-10       Impact factor: 9.410

3.  The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?

Authors:  Kevin T Shiley; Ebbing Lautenbach; Ingi Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

4.  The Alere BinaxNOW Pneumococcal Urinary Antigen Test: Diagnostic Sensitivity for Adult Pneumococcal Pneumonia and Relationship to Specific Serotypes.

Authors:  Hisashi Shoji; Arnau Domenech; Antonella Francesca Simonetti; Aida González; Dolores García-Somoza; Meritxell Cubero; Sara Martí; Masayuki Maeda; Fe Tubau; Josefina Liñares; Maria Angeles Domínguez; Jordi Carratalà; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

5.  CDS in a Learning Health Care System: Identifying Physicians' Reasons for Rejection of Best-Practice Recommendations in Pneumonia through Computerized Clinical Decision Support.

Authors:  Barbara E Jones; Dave S Collingridge; Caroline G Vines; Herman Post; John Holmen; Todd L Allen; Peter Haug; Charlene R Weir; Nathan C Dean
Journal:  Appl Clin Inform       Date:  2019-01-02       Impact factor: 2.342

6.  Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?

Authors:  Roberto Cangemi; Camilla Calvieri; Tommaso Bucci; Roberto Carnevale; Marco Casciaro; Elisabetta Rossi; Cinzia Myriam Calabrese; Gloria Taliani; Stefania Grieco; Marco Falcone; Paolo Palange; Giuliano Bertazzoni; Andrea Celestini; Pasquale Pignatelli; Francesco Violi
Journal:  Antioxid Redox Signal       Date:  2014-03-14       Impact factor: 8.401

7.  Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.

Authors:  Kalliopi Chatzika; Katerina Manika; Paschalina Kontou; Georgia Pitsiou; Despina Papakosta; Konstantinos Zarogoulidis; Ioannis Kioumis
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

8.  Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection.

Authors:  Krista L Rieger; John A Bosso; Shawn H MacVane; Zachary Temple; Amy Wahlquist; Nicole Bohm
Journal:  Pharmacotherapy       Date:  2017-10-23       Impact factor: 4.705

9.  Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.

Authors:  Barbara Ellen Jones; Jian Ying; Vanessa Stevens; Candace Haroldsen; Tao He; McKenna Nevers; Matthew A Christensen; Richard E Nelson; Gregory J Stoddard; Brian C Sauer; Peter M Yarbrough; Makoto M Jones; Matthew Bidwell Goetz; Tom Greene; Matthew H Samore
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

10.  Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.

Authors:  Danfeng Zhang; James E Gomez; Jung-Yien Chien; Nathan Haseley; Christopher A Desjardins; Ashlee M Earl; Po-Ren Hsueh; Deborah T Hung
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.